Romano Brothers & Co’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6.76M Sell
5,634
-215
-4% -$220K 0.68% 41
2026
Q1
$5.38M Sell
5,849
-63
-1% -$63.9K 0.61% 46
2025
Q4
$6.35M Sell
5,912
-158
-3% -$151K 0.72% 34
2025
Q3
$4.63M Buy
6,070
+38
+0.6% +$28.3K 0.53% 54
2025
Q2
$4.7M Sell
6,032
-18
-0.3% -$14K 0.58% 48
2025
Q1
$5M Buy
6,050
+531
+10% +$442K 0.65% 47
2024
Q4
$4.26M Sell
5,519
-7
-0.1% -$5.8K 0.54% 54
2024
Q3
$4.9M Buy
5,526
+37
+0.7% +$33.3K 0.61% 48
2024
Q2
$4.97M Buy
5,489
+29
+0.5% +$23.2K 0.69% 41
2024
Q1
$4.25M Sell
5,460
-263
-5% -$187K 0.58% 52
2023
Q4
$3.34M Sell
5,723
-330
-5% -$193K 0.5% 65
2023
Q3
$3.25M Buy
6,053
+112
+2% +$57.7K 0.51% 64
2023
Q2
$2.79M Buy
5,941
+65
+1% +$27.3K 0.42% 80
2023
Q1
$2.02M Buy
5,876
+1,456
+33% +$491K 0.31% 99
2022
Q4
$1.62M Sell
4,420
-1,000
-18% -$355K 0.25% 107
2022
Q3
$1.75M Buy
+5,420
New +$1.72M 0.28% 102

Other funds holding LLY

Romano Brothers & Co's LLY Position: Q2 2026 in Review

Romano Brothers & Co reduced its Eli Lilly (LLY) stake by 3.7% in Q2 2026, selling an estimated $220K and leaving 5,634 shares worth $6.76M. The position accounts for 0.68% of the portfolio, ranked #41.

Romano Brothers & Co first reported a position in LLY in Q3 2022 and has held it in 16 quarters since. 1,691 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Romano Brothers & Co held 5,634 shares of Eli Lilly worth $6.76M as of Q2 2026.
  • Romano Brothers & Co sold 215 Eli Lilly shares in Q2 2026, an estimated $220K.
  • Eli Lilly made up 0.68% of Romano Brothers & Co's portfolio in Q2 2026, its #41 holding.
  • Romano Brothers & Co first reported a position in Eli Lilly in Q3 2022 and has held it in 16 quarters since.
  • 1,691 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Romano Brothers & Co's 13F filing for Q2 2026, filed 22 Jul 2026.